Diabetes Drug Invokana and Amputation Risk
The U.S. Food and Drug Administration (FDA) informed manufacturing giant Johnson & Johnson in May, 2017 that they must put new warning labels on diabetes drug, Invokana (generic, canagliflozin), and its variations, Invokamet and Invokamet XR. The new warning is to alert the consumer to the clinical study findings that taking the diabetes drug can […]